Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

A Little Patience Could Go a Long Way For ZOM Stock

ZOM stock is trading below $1 as investors are in a holding pattern as they wait for the company to report earnings in August.

Don’t Give Up on QuantumScape Just Yet

QS stock looks overvalued and may have further to drop. However, a new hire indicates the company may have a better outlook later this year.

Hyliion Is Difficult to Judge Without Quantitative Metrics

Hyliion CEO Thomas Healy advises employees to not let the HYLN stock price become their focus, but investors should remain cautious.

MicroVision Stock Is Still Overvalued Despite Bullish Sentiment

Despite support from Reddit traders and the potential for explosive growth in its sector, there are signs that MVIS stock is overvalued.  

Canoo Stock Is Priced Low Enough to Be Worth a Second Look

Canoo faces many hurdles, but also has many opportunities. With a range of outcomes possible for GOEV stock, the wise strategy is to hold.